Goldilocks Zone IP Law
Alpha-aminoamide derivative compound and pharmaceutical composition comprising same
The present disclosure relates to an α-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.
NeuroBiogen Co., Ltd.
C C A C A A C C C
C07C C07C A61K C07C A61P A61K C07B C07C C07C
inventional inventional inventional inventional inventional inventional additional inventional inventional
Sun Joon Yong Koo Ae Nim Seon Mi Hyun Ah Seul Ki Ki Duk ChangJoon Justin Eun Ji Ji Won Min Ho Bo Ko Dong Jin Yun Kyung Jong-Hyun Hyo Jung Jun Young
Min Kang Pae Jo Choo Yeon Park Lee Ju Choi Nam Jang Kim Kim Park Song Heo